Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer

被引:2
|
作者
Wang, Shu [1 ]
Siddiqui, Mohummad Minhaj [1 ,2 ]
机构
[1] Univ Maryland, Sch Med, Dept Surg, Div Urol, College Pk, MD 20742 USA
[2] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA
来源
JOURNAL OF UROLOGY | 2019年 / 202卷 / 05期
关键词
Biopsy; Image-guided; Interventional; Magnetic resonance imaging; Prostate-specific antigen; Prostatic neoplasms; Ultrasonography;
D O I
10.1097/01.JU.0000580468.57731.da
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: There exists a growing debate as to whether multiparametric magnetic resonance imaging with fusion transrectal ultrasound guided prostate biopsy alone without a standard template biopsy is sufficient to evaluate patients with suspected prostate cancer. Our objective was to describe our experience with fusion targeted prostate biopsy and assess whether it could obviate the need for concomitant standard 12-core template prostate biopsy. Materials and Methods: We retrospectively reviewed our prospectively collected database of patients who underwent fusion transrectal ultrasound guided prostate biopsy. All images and lesions were graded according to the Prostate Imaging Reporting and Data System, version 2. All patients underwent targeted biopsy followed by standard 12-core double sextant biopsy within the same session. Clinically significant prostate cancer was defined as Grade Group 2 or greater prostate cancer. Results: A total of 506 patients were included in analysis. Indications were elevated prostate specific antigen with a previous negative prostate biopsy in 46% of cases, prostate cancer on active surveillance in 35%, elevated prostate specific antigen without a prior prostate biopsy in 15% and an isolated abnormal digital rectal examination in 3%. For standard vs fusion prostate biopsy the overall cancer detection rate was 57.7% vs 54.0% (p[0.12) and the clinically significant prostate cancer detection rate was 24.7% vs 30.8% (p[0.001). Of the 185 patients diagnosed with clinically significant prostate cancer 29 (16%) would have been missed if only targeted fusion prostate biopsy had been performed. Conclusions: Fusion targeted prostate biopsy is associated with a higher detection rate of clinically significant prostate cancer compared to standard double sextant biopsy. However, standard double sextant biopsy should still be performed as part of the routine fusion targeted prostate biopsy procedure to avoid missing a significant proportion of clinically significant prostate cancer. © 2019 by American UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.
引用
收藏
页码:953 / 953
页数:1
相关论文
共 50 条
  • [1] MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER
    Hanna, Nawar
    Wszolek, Matthew F.
    Gelpi-Hammerschmidt, Francisco J.
    Salari, Keyan
    Harisinghani, Mukesh
    Dahl, Douglas M.
    Blute, Micheal L.
    Feldman, Adam S.
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E491 - E492
  • [2] Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection
    Wang, Shu
    Siddiqui, M. Minhaj
    [J]. JOURNAL OF UROLOGY, 2022, 207 (01): : 93 - 93
  • [4] Transperineal multiparametric magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy combined with standard template improves perineural invasion detection
    Wu, Chin-Lee
    Kim, Michelle
    Wu, Shulin
    Lin, Sharron X.
    Crotty, Rory K.
    Harisinghani, Mukesh
    Feldman, Adam S.
    Dahl, Douglas M.
    [J]. HUMAN PATHOLOGY, 2021, 117 : 101 - 107
  • [5] Detection of extraprostatic extension by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted combined with systemic template prostate biopsy
    Hao-Wen Chuang
    Shulin Wu
    Sharron X. Lin
    Ting Zhao
    Michelle M. Kim
    Mukesh Harisinghani
    Adam S. Feldman
    Douglas M. Dahl
    Chin-Lee Wu
    [J]. Diagnostic Pathology, 18
  • [6] Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy Improves Cancer Detection Following Transrectal Ultrasound Biopsy and Correlates With Multiparametric Magnetic Resonance Imaging
    Pinto, Peter A.
    Chung, Paul H.
    Rastinehad, Ardeshir R.
    Baccala, Angelo A., Jr.
    Kruecker, Jochen
    Benjamin, Compton J.
    Xu, Sheng
    Yan, Pingkun
    Kadoury, Samuel
    Chua, Celene
    Locklin, Julia K.
    Turkbey, Baris
    Shih, Joanna H.
    Gates, Stacey P.
    Buckner, Carey
    Bratslavsky, Gennady
    Linehan, W. Marston
    Glossop, Neil D.
    Choyke, Peter L.
    Wood, Bradford J.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (04): : 1281 - 1285
  • [7] Detection of extraprostatic extension by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted combined with systemic template prostate biopsy
    Chuang, Hao-Wen
    Wu, Shulin
    Lin, Sharron X.
    Zhao, Ting
    Kim, Michelle M.
    Harisinghani, Mukesh
    Feldman, Adam S.
    Dahl, Douglas M.
    Wu, Chin-Lee
    [J]. DIAGNOSTIC PATHOLOGY, 2023, 18 (01)
  • [8] 912 Comparison of Magnetic Resonance Imaging Cognitive Prostate Biopsy Versus Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy in The Detection of Prostate Cancer
    Bhojwani, A.
    Desai, C.
    Ehsanullah, S. A.
    Shahzad, S. A.
    [J]. BRITISH JOURNAL OF SURGERY, 2021, 108 (SUPPL 2)
  • [9] Detection of Clinically Significant Prostate Cancer by Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in Smaller Prostate
    Wu, Shulin
    Dahl, Douglas
    Kim, Michelle
    Lin, Sharron
    Crotty, Rory
    Cornejo, Kristine
    Harisinghani, Mukesh
    Feldman, Adam
    Wu, Chin-Lee
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 697 - 698
  • [10] Detection of Clinically Significant Prostate Cancer by Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in Smaller Prostate
    Wu, Shulin
    Dahl, Douglas
    Kim, Michelle
    Lin, Sharron
    Crotty, Rory
    Cornejo, Kristine
    Harisinghani, Mukesh
    Feldman, Adam
    Wu, Chin-Lee
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 697 - 698